Text Size
761 studies found for:    psoriasis

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Efficacy Study of the Combination Mometasone + Salicylic Acid in Patients With Psoriasis
Condition: Psoriasis
Intervention: Drug: memotasone + salicylic acid
2 Suspended Effectiveness of Association Mometasone Furoate 0.1% and Salicylic Acid 5% Compared With Mometasone Furoate
Condition: Plaque Psoriasis
Interventions: Drug: mometasone furoate + salicylic acid;   Drug: Mometasone furoate
3 Completed
Has Results 		Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis
Conditions: Nail Psoriasis;   Plaque Psoriasis
Intervention: Drug: etanercept
4 Recruiting Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab
Condition: Moderate to Severe Plaque-type Psoriasis
Interventions: Drug: Secukinumab (AIN457);   Drug: Placebo
5 Recruiting Serum Lipid Levels and Other Biomarkers of Cardiovascular Disease in Patients With Psoriasis
Conditions: Psoriasis;   Cardiovascular Diseases;   Dyslipidemia
Intervention:
6 Active, not recruiting Prevalence of Sleep Disturbances in Psoriasis
Condition: Psoriasis
Intervention:
7 Not yet recruiting Tofacitinib Ointment For Chronic Plaque Psoriasis
Conditions: Psoriasis Vulgaris;   Psoriasis
Interventions: Drug: tofacitinib ointment 20 mg/g;   Drug: tofacitinib ointment 10 mg/g;   Drug: placebo ointment (vehicle)
8 Active, not recruiting Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice
Condition: Moderate to Severe Plaque Psoriasis
Intervention:
9 Active, not recruiting Peds Metabolic Syndrome in Psoriasis
Conditions: Psoriasis;   Metabolic Syndrome
Intervention:
10 Recruiting Effectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbidities
Conditions: Moderate to Severe Plaque Psoriasis;   Antibodies;   Monoclonals
Intervention:
11 Completed
Has Results 		Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis
Conditions: Plaque Psoriasis;   Psoriasis Vulgaris
Interventions: Drug: Taclonex Ointment and Hydrogel Patch;   Drug: Taclonex Ointment
12 Completed A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis
Condition: Moderate and Severe Plaque Psoriasis
Interventions: Drug: Placebo;   Drug: AEB071
13 Recruiting A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With Psoriasis
Conditions: Psoriasis;   Nonalcoholic Fatty Liver Disease
Intervention:
14 Completed
Has Results 		Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biologic Disease Modifying Anti-rheumatic Drugs
Condition: Psoriasis Chronic
Intervention:
15 Completed
Has Results 		Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis
Conditions: Plaque Psoriasis;   Psoriasis
Intervention: Drug: Etanercept
16 Recruiting The Effect of Weight Loss on Psoriasis Area Severity Index in Adult Psoriasis Patients
Conditions: Psoriasis;   Obesity
Intervention: Behavioral: Weight Loss
17 Completed
Has Results 		A Study of Effectiveness and Safety of Tumor Necrosis Factor (TNF) Inhibitors in Patients With Moderate to Severe Psoriasis
Condition: Psoriasis
Intervention:
18 Completed
Has Results 		Open Label Study Etanercept's Maintenance Dose in Obese Patients With Moderate to Severe Plaque Type Psoriasis
Condition: Psoriasis
Interventions: Procedure: Narrow band (310-312 nm) ultraviolet light B phototherapy;   Drug: etanercept
19 Recruiting Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis
Conditions: Psoriasis;   Psoriatic Arthritis
Interventions: Drug: Apremilast 30 mg;   Drug: Etanercept 50 mg;   Drug: Placebo tablet;   Drug: Placebo injection (saline)
20 Completed
Has Results 		Immediate Response With Adalimumab and Its Impact on Quality of Life and Other Comorbidity Factors in Patients With Moderate to Severe Plaque Psoriasis
Condition: Psoriasis
Intervention: Biological: Adalimumab
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years